UK and UK HealthCare experts are sharing their personal experiences and recommendations about life after vaccination against COVID-19.
LEXINGTON, Ky. (April 20, 2021) – We are to a point now that seemed nearly impossible one year ago – having millions vaccinated against COVID-19.
Thanks to the hard work and dedication of UK HealthCare and University of Kentucky employees and volunteers, hundreds of thousands of emergency authorized vaccines have been distributed to Kentuckians. The COVID-19 vaccination clinic at Kroger Field surpassed 200,000 vaccines in the beginning of April.
As people continue to schedule their shots, many are breathing a sigh of relief – including experts at UK who have been helping our community navigate the coronavirus from the start. Whether working on the front lines and treating COVID-19 positive patients at UK Chandler Hospital, or breaking down the complicated processes that have brought us to where we are today, they are sharing their thoughts a
Photo credit: iStock / Getty Images Plus.
The University of Kentucky Public Relations & Strategic Communications Office provides a weekly health column available for use and reprint by news media. This week s column is by Dr. Daniel Lee, medical director for the Kentucky Neuroscience Institute.
LEXINGTON, Ky. (April 19, 2021) One out of three individuals in the U.S. complain of sleep disturbances in their lifetime and 10% of the general population meet the diagnostic criteria of chronic sleep disorders. That number has risen among elderly individuals to 48% and over 50% among pregnant women. Our knowledge and understanding of sleep health have evolved over the past four decades. More than 100 specific sleep disorders have been identified. Sleep disorders require a dedicated team to provide a comprehensive approach to tackle the intricacies of complex sleep problems.
of
LEXINGTON, Ky. (April 16, 2021) Dr. Larry Goldstein, chair of the University of Kentucky Department of Neurology, has been elected to serve on the board of directors of The American Academy of Neurology (AAN). Goldstein also is co-director of the Kentucky Neuroscience Institute, co-director of the UK Neuroscience Research Priority Area and interim director of the UK-Norton Healthcare Stroke Care Network.
Goldstein received his bachelor s degree in 1977 from Brandeis University and his medical degree from Mount Sinai School of Medicine in 1981. His subsequent professional training included an internship and neurology residency at Mount Sinai Medical Center, New York (1981-1985) and a research fellowship in cerebrovascular disease at Duke University (1985-1987). Goldstein advanced at Duke University to the rank of professor of neurology and director of the Duke Stroke Center prior to moving to the University of Kentucky in 2015.
of
LEXINGTON, Ky. (April 14, 2021) UK HealthCare’s Multiple Sclerosis (MS) Center, a part of the Kentucky Neuroscience Institute, is celebrating one of its biggest achievements since it was created about three decades ago. The MS Center is now recognized as a Center for Comprehensive Care by the National Multiple Sclerosis Society. To achieve this status a center must address the needs of those living with MS by coordinating multi-disciplinary care, from medical, psycho-social and rehabilitation services, to provide exceptional care.
“Being called a Comprehensive MS Care Center implies that physicians of multiple subspecialties come together under one roof for the patients, the availability of this kind of expertise offers a tremendous breadth of services available,” says Dr. Jay Avasarala, professor of neurology, who leads the MS team at UK HealthCare.
From UK Now:
The University of Kentucky s Sanders-Brown Center on Aging (SBCoA) is partnering with the Lewy Body Dementia Association (LBDA) to host a virtual panel discussion and screening of a documentary about comedian Robin Williams and his undiagnosed Lewy body dementia (LBD) at 6 p.m., April 8.
The educational film titled,
Spark, delves deeper into the disease, its biology, myriad of clinical symptoms and its impact on both the person with LBD and the primary caregiver.
After viewing the film together virtually, attendees are encouraged to discuss the films’ content, key themes and important messages. To encourage this discussion, after the viewing a select group of speakers will present about the disease and then will facilitate a Q&A session.